CD4 and cancer: (59), found a relationship between systemic inflammatory response and local inflammatory response in patients undergoing resection for CRC, demonstrating that a high concentration of C-reactive protein and low tumor-infiltrating CD4+ are predictive of poor cancer-specific survival.